期刊文献+

S-TK1在乳腺癌患者中检测的意义及其与预后的关系 被引量:2

Significance of S-TK1 Detecting in Breast Cancer Patients and Its Relationship with Pragnosis
暂未订购
导出
摘要 目的研究S-TK1含量在乳腺癌、乳腺良性肿瘤患者及健康体检人群中的差别;探讨S-TK1与乳腺癌的关系,探讨乳腺癌患者S-TK1的含量与肿瘤分期、肿块大小、组织学分级、ER、PR及HER-2之间的关系;进而分析S-TK1含量与乳腺癌患者复发、转移的关系。方法采用化学发光点印迹法,分析乳腺癌、乳腺良性肿瘤患者及健康体检者S-TK1的含量。结果 (1)乳腺癌患者治疗前(A组)、乳腺良性肿瘤患者(B组)及健康体检者(C组)S-TK1的含量分别为(17.98±10.20)pmol/L,(1.50±1.02)pmol/L,(0.88±0.45)pmol/L。A组S-TK1的含量明显高于B组和C组,差异有统计学意义(P均<0.001);B组S-TK1的含量高于C组,差异有统计学意义(P=0.017)。A组Ⅲ期乳腺癌患者S-TK1的含量(21.54±11.85)pmol/L高于Ⅱ期患者(14.05±6.19)pmol/L,差异有统计学意义(P=0.018)。(2)S-TK1的含量与组织学分级、HER-2及肿块大小均呈正相关(其相关系数分别为r=0.596、0.324、0.397,对应的P值为P<0.001、=0.042、=0.011);而ER与S-TK1的含量呈负相关(其r=-0.391,P=0.013);PR与S-TK1的含量无相关性(P=0.395,r=-0.138)。(3)复发转移组治疗前S-TK1含量(23.17±13.15)pmol/L明显高于无病生存组(14.31±5.50)pmol/L,差异有统计学意义(P=0.011),S-TK1低值组和中值组无病生存高于S-TK1高值组,但差异无统计学意义(P=0.186)。结论 S-TK1也许可以作为乳腺癌早期诊断的指标之一;S-TK1含量与乳腺癌患者的预后有关,治疗前高S-TK1含量可能更容易早期出现复发、转移。 Objective To study the difference of S-TK1 level among patients with breast cancer,patients with benign breast tumor and healthy volunteers,to investigate the correlation between S-TK1 level and staging,the size of tumor,grade,ER,PR or HER-2 in patients with breast cancer and analyze the mechanism that S-TK1 involved into the recurrence and metastasis of breast cancer patients.Methods The S-TK1 levels of breast cancer,breast benign tumor and healthy volunteers were detected by enhanced chemiluminescence(ECL) dot blot assay.Results(1)The concentrations of S-TK1 in patients with breast cancer before treatment(group A),benign breast tumor(group B)(17.98±10.20)pmol/L,and healthy volunteers(group C)(1.50±1.02)pmol/L and(0.88±0.45)pmol/L,respectively.There was significant difference between group A and group B or group C(P0.001,P0.001),and between group B and group C(P=0.017).Also in group A the concentration of S-TK1 of staging Ⅲ was significantly higher than that of staging Ⅱ,(21.54±11.85)pmol/L vs.=(14.05±6.19)pmol/L(P=0.018).(2)There was a positive correlation between the concentration of S-TK1 with grade,HER-2 and the size of tumor(r=0.596,0.324,0.397,P0.001,P=0.042,P=0.011,respectively) and a negative correlation between ER and the concentration of S-TK1(r=-0.391,P=0.013).But the concentration of S-TK1 had correlation with PR(P=0.395,r=-0.138);(3)The S-TK1 level in patients with recurrence and metastasis before therapy was higher than that in disease-free patients,(23.17±13.15)pmol/L vs.(14.31±5.50)pmol/L(P=0.011).The DFS in low and middle S-TK1 level was longer than that in high S-TK1 level,but there was not significant diference(P=0.138).Conclusion S-TK1 perhaps could be one of markers for early breast cancer diagnosis.The level of S-TK1 has relation with the progress of breast cancer,and results into recurrence and metastasis.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2012年第6期637-641,共5页 Cancer Research on Prevention and Treatment
关键词 胸苷激酶-1 乳腺癌 化学发光点印迹 Thymidine kinase-1 Breast cancer Enhanced chemiluminescence dot blot assay
  • 相关文献

参考文献14

  • 1Elsevier SM, Kucherlapati RS, Nichols EA, et al. Assignment of the gene for galactokinase to human chromosome 17 and its regional localisation to band q21-22[J]. Nature, 1974, 251 (5476) :633-6.
  • 2Welin M, Kosinska U, Mikkelsen NE, et al. Structures of thy- midine kinase 1 of human and mycoplasmle origin[J]. Proe Natl Sci U S A,2004,101(52):17970-5.
  • 3Sherley JL, Kelly TJ. Regulation of human thymidine kinase during the cell cycle[J]. J Biol Chem, 1988,263 (17) : 8350-8.
  • 4He Q,Fornander T,Johansson H,et al. Thymidine kianse 1 in serum prediets increased risk of distant or loeo-regional recur- rence following surgery in patients with early breast cancer [J].AntleancerRes,2006,26(6C):4753 9.
  • 5He Q, Zhang P, Zou L, et al. Concentration of thymidine kinase 1 in serum(S-TK1 ) is a more sensitive proliferation marker in human solid tumors than its activity[J]. Oncology Rep, 2005, 14(4) : 1013-9.
  • 6Nisman B, Allweis T, Kaduri L, et al. Serum thymidine kinase 1 activity in breast cancer[J]. Cancer Biomark, 2010, 7 (2): 65-72.
  • 7Li HX,Lei DS,Wang XQ,et al. Serum thymidine kinase 1 is a prognostic and monitoring factor in patients with non-small cell lung cancer[J]. Oncol Rep,2005,13( 1 ) :145 9.
  • 8He QM, Zou L, Zhang PA, et al. The clicinal significance of thymidine kinase 1 measurement in serum of breast cancer pa- tients using anti-TK1 antiboty[J]. Int J Biol Markers,2000,15 (2) :139-46.
  • 9李艳,张平安,邹力,何其敏.免疫印迹法测定乳腺肿瘤患者胸苷激酶[J].中华检验医学杂志,2000,23(6):334-336. 被引量:24
  • 10Mao Y,Wu J,Wang N,et al. A comparative study:immunohis- tochemical detection of cytosolic thymidine kinase and prolifer- ating cell nuclear antigen in breast caneer[J]. Cancer Invest, 2002,20 (7-8) : 922-31.

二级参考文献16

  • 1张毅,沈炜明.癌基因与肿瘤治疗[J].上海医学,2002,25(z1):126-128. 被引量:1
  • 2孙治君,周鑫,管小琴.表皮生长因子受体、C-erbB_2和细胞增殖核抗原联合检测判断乳腺癌的预后[J].临床外科杂志,2005,13(5):274-276. 被引量:2
  • 3李占文,李振平,胡云锵,杨华峰,刘纯,贺亚娟.176例Ⅱ、Ⅲ期乳腺癌腋淋巴结转移临床病理相关因素分析[J].临床外科杂志,2005,13(5):282-284. 被引量:11
  • 4He Q,3rd Hong Kong Int Cancer Congress 7th International EBV Symposium,1996年,52卷,13页
  • 5He Q,Eur J Cell Biol,1996年,70卷,117页
  • 6LOWER E E,CLASS E L,BRADLEY D A,et al.Impact of metastatic estrogen receptor and progesterone receptor status on survival[J].Breast Cancer Res Treat,2005,90(1):65-70.
  • 7LOCKER G Y.Hormonal therapy of breast cancer[J].Cancer Treat Rev,1998,24(3):1 221-1 240.
  • 8MCGUIRE M L.Prognostic factors for recurrence and survival in human breast cancer[J].Breast Cancer Res Treat,1987,10:5-9.
  • 9Anonymous.Adjuvant tamoxifen in the uthe management of operable breast causer:the Scottish Trial-Report from the Breast Cancer Tirals Connnittee,Scottish Cancer Triale Office(MRC),Edinburgh[J].Lancet,1987,2(8552):171-175.
  • 10FISHER E R,SASS R,FISHER B,et al.Patholgic findings from the National Surgical Adjuvant Breast Project(protocol 6):Ⅱ.Relation of local breast recurrence to multicentricity[J].Cancer,1986,57:1 717-1 724.

共引文献29

同被引文献31

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部